What does Trump's latest cannabis order mean for consumers?
The order recognizes marijuana's medical use and directs Congress to revisit hemp THC limits while launching a Medicare program for doctor-recommended CBD for seniors.
- On Thursday, President Donald Trump signed an executive order reclassifying marijuana from Schedule 1 to Schedule 3, but The White House said it does not legalize marijuana federally or endorse recreational use.
- The rescheduling push began under the Biden administration and the Trump order directs the attorney general to accelerate rescheduling and asks White House policy staff to work with Congress on hemp product restrictions passed earlier this year.
- The Schedule 3 designation signals an accepted medical use, and President Donald Trump said 'This reclassification order will make it far easier to conduct marijuana-related medical research, allowing us to study benefits, potential dangers, and future treatments'.
- The order asks Congress to revisit per-container THC limits and hemp restrictions passed earlier this year, while White House officials said it does not change criminal penalties.
- The administration announced a Medicare program to let certain older adults access doctor-recommended CBD at no cost starting as early as April 2026, with supporters citing business benefits but Dr. Kevin Sabet warning, 'This rule, if finalized, will herald a public health disaster.
182 Articles
182 Articles
Trump expedites marijuana reclassification: Ohio cannabis businesses to benefit
President Donald Trump signed an executive order last week directing the Attorney General to expedite the reclassification of marijuana from a Schedule I down to a Schedule III substance in the Controlled Substances Act, a move that is expected to be a major financial win for Ohio’s cannabis industry.
Veterans groups, cannabis businesses laud Trump order for helping ease stigma, reshape public views on medical marijuana
The executive order is significant to the cannabis industry for its support of more research, stronger standards and ending negative stereotypes.
Coverage Details
Bias Distribution
- 62% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium






























